140 related articles for article (PubMed ID: 11332203)
1. The role of fibronectin in bronchoalveolar lavage fluid of asthmatic patients.
Ohke M; Tada S; Nabe M; Matsuo K; Kataoka M; Harada M
Acta Med Okayama; 2001 Apr; 55(2):83-9. PubMed ID: 11332203
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive pulmonary diseases.
Song WD; Zhang AC; Pang YY; Liu LH; Zhao JY; Deng SH; Zhang SY
Respiration; 1995; 62(3):125-9. PubMed ID: 7569331
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibronectin in asthmatic patients and its relation to asthma attack.
Ohke M; Tada S; Kataoka M; Matsuo K; Nabe M; Harada M
Acta Med Okayama; 2001 Apr; 55(2):91-6. PubMed ID: 11332204
[TBL] [Abstract][Full Text] [Related]
4. [Changes of extracellular matrix components in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis].
Zhao H; Chen B; Li Z
Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):457-60. PubMed ID: 10436946
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin in bronchoalveolar lavage fluid in lung cancer: tumor or inflammatory marker?
Cremades MJ; Menéndez R; Rubio V; Sanchis J
Respiration; 1998; 65(3):178-82. PubMed ID: 9670297
[TBL] [Abstract][Full Text] [Related]
6. Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children.
Goldman DL; Li X; Tsirilakis K; Andrade C; Casadevall A; Vicencio AG
Clin Exp Allergy; 2012 Apr; 42(4):523-30. PubMed ID: 22092749
[TBL] [Abstract][Full Text] [Related]
7. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids.
Van Hal PT; Overbeek SE; Hoogsteden HC; Zijlstra FJ; Murphy K; Oosterhoff Y; Postma DS; Guz A; Smith SF
J Appl Physiol (1985); 1996 Aug; 81(2):548-55. PubMed ID: 8872617
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Zhao HW; Lu CJ; Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776
[TBL] [Abstract][Full Text] [Related]
9. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid.
Meerschaert J; Kelly EA; Mosher DF; Busse WW; Jarjour NN
Am J Respir Crit Care Med; 1999 Feb; 159(2):619-25. PubMed ID: 9927382
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor levels and localisation in human asthmatic bronchi.
Olgart Höglund C; de Blay F; Oster JP; Duvernelle C; Kassel O; Pauli G; Frossard N
Eur Respir J; 2002 Nov; 20(5):1110-6. PubMed ID: 12449162
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma.
Torregrosa Paredes P; Esser J; Admyre C; Nord M; Rahman QK; Lukic A; Rådmark O; Grönneberg R; Grunewald J; Eklund A; Scheynius A; Gabrielsson S
Allergy; 2012 Jul; 67(7):911-9. PubMed ID: 22620679
[TBL] [Abstract][Full Text] [Related]
12. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics.
Folkard SG; Westwick J; Millar AB
Eur Respir J; 1997 Sep; 10(9):2097-104. PubMed ID: 9311510
[TBL] [Abstract][Full Text] [Related]
13. Concentration of endothelin in plasma and BALF fluid from asthmatic patients.
Gawlik R; Jastrzebski D; Ziora D; Jarzab J
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():103-10. PubMed ID: 17072036
[TBL] [Abstract][Full Text] [Related]
14. Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects.
Plummeridge MJ; Armstrong L; Birchall MA; Millar AB
Thorax; 2000 Oct; 55(10):842-7. PubMed ID: 10992536
[TBL] [Abstract][Full Text] [Related]
15. Quantification of fibronectin in bronchoalveolar lavage fluid and in lung parenchyma: differences between smokers and non-smokers.
Menéndez R; Marco V; Rubio V; Solé A
Respiration; 1995; 62(6):312-6. PubMed ID: 8552861
[TBL] [Abstract][Full Text] [Related]
16. Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans.
Larsson N; Lundström SL; Pinto R; Rankin G; Karimpour M; Blomberg A; Sandström T; Pourazar J; Trygg J; Behndig AF; Wheelock CE; Nording ML
Eur Respir J; 2014 Feb; 43(2):453-63. PubMed ID: 24036245
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Jahnz-Rózyk KM; Kuna P; Pirozyńska E
J Investig Allergol Clin Immunol; 1997; 7(4):254-9. PubMed ID: 9330191
[TBL] [Abstract][Full Text] [Related]
18. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572
[TBL] [Abstract][Full Text] [Related]
19. Detection of a novel macrophage-derived mucus secretagogue (MMS-68) in bronchoalveolar lavage fluid of patients with asthma.
Sperber K; Chanez P; Bousquet J; Goswami S; Marom Z
J Allergy Clin Immunol; 1995 Apr; 95(4):868-76. PubMed ID: 7722168
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: a potential mechanism of anti-asthmatic effect of thalidomide.
Lee HS; Kwon HS; Park DE; Woo YD; Kim HY; Kim HR; Cho SH; Min KU; Kang HR; Chang YS
PLoS One; 2015; 10(4):e0123094. PubMed ID: 25905462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
